Company profile
BridgeBio Pharma, Inc. Insider Trading
BBIOEvery SEC Form 4 insider trading filing for BridgeBio Pharma, Inc. (BBIO) since April 2023: open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0001743881
- Filings
- 193
- Insiders
- 34
- Last filing
- 2026-09-17
Activity summary
No discretionary insider buying or selling in the last 30 days. The 2 transactions filed were made under a 10b5-1 plan, scheduled in advance rather than decided on the day.
Three year balance
Buy and sell value by quarter, Q4 23 to Q3 26. BridgeBio Pharma, Inc. insiders are net sellers across the period shown.
Bars below the rule are sales, above are purchases. Largest quarter on the chart is $377.2M.
90 day insight
Over the last 90 days, BridgeBio Pharma, Inc. insiders filed 32 Form 4 transactions, none of which were open-market purchases or sales.
- Most active insider: Neil Kumar with 18 transactions totaling $7.3M.
- Largest single sale: $10.1M by Jennifer E. Cook on Jul 9, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades, typically less informative than open-market activity.
Activity skews bullish: buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Neil Kumar | BBIO | Sale10b5 | 8,721 | $69.01 | $602K |
| Sep 17, 2026 | Neil Kumar | BBIO | Sale10b5 | 1,279 | $69.57 | $89K |
| Aug 19, 2026 | Neil Kumar | BBIO | Sale10b5 | 8,100 | $83.86 | $679K |
| Aug 19, 2026 | Neil Kumar | BBIO | Sale10b5 | 1,800 | $84.69 | $152K |
| Aug 19, 2026 | Neil Kumar | BBIO | Sale10b5 | 100 | $85.65 | $9K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=BBIO" \
-H "X-Api-Key: $KEY"Top insiders
By open-market value traded.
Institutional Ownership
Top 13F-HR holders of BridgeBio Pharma, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings: institutional holders report positions within 45 days of quarter end. Joined with insider activity above: see who's loading up institutionally while insiders are trading. Full 13F-HR API →